The Effect of Intraoperative Esketamine Infusion on Pruritus in Elderly Surgical Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-80
SponsorTianjin Medical University General Hospital

About this trial

To explore the effect of intraoperative esketamine on pruritus in elderly patients undergoing elective general anesthesia for knee replacement surgery

Eligibility criteria

Qualifiers

Aged ≥ 65 years old;

Presenting with only skin pruritus without obvious primary skin lesions, with or without scratch-induced skin lesions;

Daily or nearly daily pruritus lasting for more than 6 weeks.

Patients undergoing elective general anesthesia for orthopedic knee arthroplasty.

Disqualifiers

Those who are allergic to the pharmaceutical ingredients of this study or have an allergic constitution;

Those with a history of allergy to general anesthetics, opioids, or non-steroidal anti-inflammatory drugs;

Those with severe cognitive impairment, a history of neurological diseases, chronic pain, drug addiction, alcoholism, long-term opioid use, or administration of opioids within 48 hours before surgery;

Patients with ASA physical status classification Grade IV-V;

Trial design

Treatments tested in this trial

  • Esketamine
  • Normal Saline

Treatment groups

200 Participants
are divided into 2 treatment groups